Report : Asia Pacific 3D Printing Medical Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Software and Services, Equipment {3D Printers, 3D Bioprinters}, Materials {Plastics Material, Metal and Metal Alloys, Bioprinting Biomaterial, Wax Material, and Others}), Technology (Laser Beam Melting {Direct Metal Laser Sintering, Selective Laser Sintering, Selective Laser Melting, LaserCusing}, Photopolymerization {Stereolithography, Others}, Droplet Deposition/Extrusion Based Technologies {Fused Deposition Modelling, Multiphase Solidification, Low Temperature Deposition Manufacturing}, Electron Beam Melting ), Application (Custom Prosthetics and Implants {Craniomaxillofacial Implants, Custom Dental Prosthetics and Implants, Custom Orthopedic Implants}, Surgical Guides {Dental Orthopedic, Craniomaxillofacial, Spinal Guides}, Tissue Engineering Products {Bone and Cartilage Scaffolds, Ligament and Tendons Scaffolds}, Surgical Instruments {Surgical Fasteners, Scalpels, Retractors}, Hearing Aids, Wearable Medical Devices, Standard Prosthetics and Implants), and End-User (Hospitals and Surgical Centers, Dental and Orthopedic Centers, Medical Device Companies, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others)
Software and Services Segment has the Largest Share of Component in the Asia Pacific 3D Printing Medical Devices Market during 2021–2028
According to our latest study on “Asia Pacific 3D Printing Medical Devices Market Forecast to 2028 – COVID-19 Impact and Analysis – by Component, Technology, Application, and End-User,” the market is projected to reach US$ 1,415.5 million by 2028 from US$ 438.8 million in 2021; it is expected to grow at a CAGR of 18.2% from 2021 to 2028. The report highlights trends prevailing in the market, and the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the rising incidences of cancer and increasing adoption of metabolomics and investments by market players. However, high cost of tools, instruments, and usage is expected to restrict the market growth during the forecast period.
The spread of the COVID-19 pandemic has emphasized health data sharing and interoperability under the microscope. Pediatric coronavirus disease-19 (COVID-19) infection is comparatively mild compared to adults, and children are assigned a better prognosis. The interruptions in the supply chain and the massive demand for efficient treatments for the therapy of COVID-19 have put the health research industry in the Asia-Pacific region in a crucial position. The current medical system is built on private-sector equipment. The majority of medical equipment is patented by medical companies. Suppliers are unable to provide the requisite quantity of equipment in the event of a sudden rise in demand, necessitating innovation and new manufacturing tactics. Furthermore, transportation and trade restrictions, quarantines, border controls, and production disruptions all have a significant impact on the essential medical device supply chain. Fortunately, 3D printing technology may provide a viable answer to this issue. The generated open source designs of medical equipment are freely shared using this technology.
Based on component, the 3D printing medical devices market is segmented into software and services, equipment, and material. In 2021, the material segment accounted for the largest share. Moreover, the software and services segment is expected to grow at the highest CAGR during the forecast period.
EOS GmbH Electro Optical Systems, Renishaw PLC, Stratasys Ltd., 3D Systems, Inc., EnvisionTech, Inc., Concept Laser Gmbh (General Electric), and SLM Solution Group AG are among the leading companies in the Asia Pacific 3D printing medical devices market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.
The market for 3D printing medical devices market is segmented into component, technology, application, and end-user. Based on component, the Asia Pacific 3D printing medical devices market is segmented into software and services, equipment, and material. Based on technology, the 3D printing medical devices market is segmented into laser beam melting, photopolymerization, droplet deposition/extrusion-based technology, electron beam melting, and others. Based on application, the Asia Pacific 3D printing medical devices market is segmented into custom prosthetics and implants, surgical guides, tissue engineering products, surgical instruments, hearing aids, wearable medical devices, standard prosthetics and impants, and others. Based on end-user, the Asia Pacific 3D printing medical devices market is segmented into hospitals and surgical centers, dental and orthopedic centers, medical device companies, pharmaceutical and biotechnology companies, academic and research institutions, others. Geographically, the 3D printing medical devices market is segmented into Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia Pacific).
Asia Pacific 3D Printing Medical Devices Market, By Country, 2021 and 2028 (%)
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com